focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHend.eur.focus Regulatory News (HEFT)

Share Price Information for Hend.eur.focus (HEFT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 190.50
Bid: 191.50
Ask: 193.50
Change: -2.00 (-1.04%)
Spread: 2.00 (1.044%)
Open: 190.50
High: 190.50
Low: 190.50
Prev. Close: 192.50
HEFT Live PriceLast checked at -
Henderson European Focus Trust is an Investment Trust

seeks to maximise total return from a focused portfolio of listed stocks, mainly in Continental Europe.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Results analysis from Kepler Trust Intelligence

13 Dec 2023 12:31

RNS Number : 6745W
Henderson European Focus Trust PLC
13 December 2023

Henderson European Focus Trust (HEFT)

13/12/2023

Results analysis from Kepler Trust Intelligence

Henderson European Focus's (HEFT's) NAV and share price total return for the year to 30/09/2023 were 24.1% and 27.7% respectively, outperforming the benchmark, the FTSE World Europe ex UK, which produced a total return of 20.5%. The equivalent NAV total return figure for the AIC Europe peer group was 20.0%. The trust has also outperformed its benchmark over three, five, seven and ten years. Total dividends for the year were 4.35 pence per share (2022: 4.35p). At the closing share price on 12/12/2023 of 167p this represents a yield of 2.6%.

Co-manager Tom O'Hara very recently appeared in a webinar hosted by Kepler, which can be viewed here, where among other things he made the observation that European equities are, on a forward P/E basis, cheaper than they have ever been compared to US equities. Industry fund flow data shows that during 2023, investors haven't been selling European equity funds in the huge volumes they did in 2022, but neither have they re-embraced them, with a steady drip of selling. So, despite good performance since the lows of September 2022, these low valuations may yet help turn the tide on investor sentiment, which could be very constructive for European equities generally.

HEFT is currently trading at a 13% discount. With European equities at exceptionally low valuations, and notwithstanding the strong performance of the last year, we think this could be a very good entry point for long-term investors.

CLICK HERE TO READ THE FULL REPORT Visit Kepler Trust Intelligence for more high quality independent investment trust research.

Important information

This report has been issued by Kepler Partners LLP. The analyst who has prepared this report is aware that Kepler Partners LLP has a relationship with the company covered in this report and/or a conflict of interest which may impair the objectivity of the research.

Past performance is not a reliable indicator of future results. The value of investments can fall as well as rise and you may get back less than you invested when you decide to sell your investments. It is strongly recommended that if you are a private investor independent financial advice should be taken before making any investment or financial decision.

Kepler Partners is not authorised to make recommendations to retail clients. This report has been issued by Kepler Partners LLP, is based on factual information only, is solely for information purposes only and any views contained in it must not be construed as investment or tax advice or a recommendation to buy, sell or take any action in relation to any investment.

The information provided on this website is not intended for distribution to, or use by, any person or entity in any jurisdiction or country where such distribution or use would be contrary to law or regulation or which would subject Kepler Partners LLP to any registration requirement within such jurisdiction or country. In particular, this website is exclusively for non-US Persons. Persons who access this information are required to inform themselves and to comply with any such restrictions.

The information contained in this website is not intended to constitute, and should not be construed as, investment advice. No representation or warranty, express or implied, is given by any person as to the accuracy or completeness of the information and no responsibility or liability is accepted for the accuracy or sufficiency of any of the information, for any errors, omissions or misstatements, negligent or otherwise. Any views and opinions, whilst given in good faith, are subject to change without notice.

This is not an official confirmation of terms and is not a recommendation, offer or solicitation to buy or sell or take any action in relation to any investment mentioned herein. Any prices or quotations contained herein are indicative only.

Kepler Partners LLP (including its partners, employees and representatives) or a connected person may have positions in or options on the securities detailed in this report, and may buy, sell or offer to purchase or sell such securities from time to time, but will at all times be subject to restrictions imposed by the firm's internal rules. A copy of the firm's Conflict of Interest policy is available on request.

PLEASE SEE ALSO OUR TERMS AND CONDITIONS

Kepler Partners LLP is authorised and regulated by the Financial Conduct Authority (FRN 480590), registered in England and Wales at 70 Conduit Street, London W1S 2GF with registered number OC334771.

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
NRAZZMMZZFMGFZM
Date   Source Headline
21st Jun 202312:36 pmRNSNet Asset Value(s)
20th Jun 202311:57 amRNSNet Asset Value(s)
19th Jun 20231:32 pmRNSNet Asset Value(s)
16th Jun 202311:52 amRNSNet Asset Value(s)
15th Jun 20231:36 pmRNSNet Asset Value(s)
15th Jun 202310:48 amRNSDirectorate Change
14th Jun 20231:22 pmRNSNet Asset Value(s)
13th Jun 20231:22 pmRNSNet Asset Value(s)
12th Jun 20232:30 pmRNSNet Asset Value(s)
9th Jun 20232:12 pmRNSNet Asset Value(s)
8th Jun 202312:47 pmRNSNet Asset Value(s)
7th Jun 202311:19 amRNSNet Asset Value(s)
6th Jun 202312:22 pmRNSNet Asset Value(s)
5th Jun 20232:32 pmRNSNet Asset Value(s)
2nd Jun 202312:43 pmRNSNet Asset Value(s)
1st Jun 20231:20 pmRNSNet Asset Value(s)
31st May 202312:37 pmRNSNet Asset Value(s)
30th May 20233:49 pmRNSNet Asset Value(s)
26th May 202312:37 pmRNSNet Asset Value(s)
26th May 202311:28 amRNSHalf Year Report
25th May 202311:24 amRNSResults analysis from Kepler Trust Intelligence
25th May 202310:26 amRNSNet Asset Value(s)
24th May 202312:21 pmRNSMonthly Factsheet as at 30 April 2023
24th May 202312:13 pmRNSNet Asset Value(s)
23rd May 20231:04 pmRNSNet Asset Value(s)
22nd May 20233:34 pmRNSHalf-year Report
22nd May 20231:46 pmRNSNet Asset Value(s)
19th May 20231:08 pmRNSNet Asset Value(s)
18th May 202312:46 pmRNSNet Asset Value(s)
17th May 202312:57 pmRNSNet Asset Value(s)
16th May 20231:18 pmRNSNet Asset Value(s)
15th May 20233:04 pmRNSNet Asset Value(s)
12th May 20231:29 pmRNSNet Asset Value(s)
11th May 202312:54 pmRNSNet Asset Value(s)
10th May 20231:00 pmRNSNet Asset Value(s)
9th May 20232:35 pmRNSNet Asset Value(s)
5th May 202312:47 pmRNSNet Asset Value(s)
4th May 202311:44 amRNSNet Asset Value(s)
3rd May 202311:44 amRNSNet Asset Value(s)
2nd May 20233:56 pmRNSNet Asset Value(s)
28th Apr 202312:47 pmRNSNet Asset Value(s)
27th Apr 202311:25 amRNSNet Asset Value(s)
26th Apr 20232:13 pmRNSMonthly Factsheet as at 31 March 2023
26th Apr 202311:33 amRNSNet Asset Value(s)
25th Apr 202312:03 pmRNSNet Asset Value(s)
24th Apr 20232:51 pmRNSNet Asset Value(s)
21st Apr 202311:13 amRNSNet Asset Value(s)
20th Apr 202311:57 amRNSNet Asset Value(s)
19th Apr 202312:00 pmRNSNet Asset Value(s)
18th Apr 20233:32 pmRNSCompliance with Market Abuse Regulation

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.